Ethically sourced from healthy volunteers, allogeneic MSCs are introduced with therapeutic genes (cargo) one time to minimize risks associated with genetic engineering.
A safety gene is introduced along with therapeutic genes to ensure quality control and limit the occurrence of severe adverse events
Our therapy is effective
Unlike conventional gene therapy, which struggles to deliver genes to the site of interest, our approach exploits the tumor-homing property of MSCs to facilitate gene delivery, maximizing both the efficiency and efficacy of our gene therapy.
Our product is scalable
Thanks to the proliferation capability of MSCs, we can easily scale production by orders of magnitude, creating a large quantity of homogeneous cells with the same therapeutic properties as the starting batch.
